Both PTX3 and sMR plasma concentrations were 1.7-fold increased in non-survivors when compared to survivors (p = 0.0388 and p = 0.0070, respectively) in the first few days after infection or symptom onset (day 0). The gene discussed is LYPD4; the disease is infection.